Exploring the incidence potential of phenol-soluble modulins among methicillin-resistant Staphylococcus aureus in

Sourat Mudassar1, Abida Bano1, Farah Asghar1

  • 1Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan.

BMC Infectious Diseases
|September 27, 2025
PubMed
Abstract

Insights

This study found that phenol-soluble phenol-soluble (PSMs) genes, particularly psm-β and psm-mec, are strongly associated with MRSA from pus samples. This highlights potential targets for anti-virulence strategies against MRSA infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant global health challenge.
  • Understanding MRSA's antibiotic resistance and virulence factors is crucial for effective treatment and control.

Purpose of the Study:

  • To analyze antibiotic resistance patterns in MRSA clinical isolates.
  • To investigate the prevalence of phenol-soluble (PSMs) virulence genes.
  • To determine associations between clinical specimen sources and PSM gene incidence.

Main Methods:

  • Sixty MRSA strains from various clinical sources were analyzed.
  • Antibiotic susceptibility testing was performed using the Kirby-Bauer disk diffusion method.
  • Polymerase chain reaction (PCR) was used to detect specific genes, including mecA, mecC, PSMs (psm-α, psm-β, psm-mec), and agr.

Main Results:

  • All isolates (100%) carried the 16SrRNA and mecA genes; none carried the mecC gene.
  • Vancomycin and linezolid remained effective against MRSA.
  • High prevalence of PSM genes was observed: psm-α (93.4%), psm-β (90%), psm-mec (91.6%), and agr (80%).
  • Significant associations were found between psm-β and psm-mec genes and MRSA isolates from pus samples (p < 0.05).

Conclusions:

  • PSM genes, especially psm-β and psm-mec, are linked to MRSA in pus, suggesting their role in virulence.
  • Findings support the development of anti-virulence strategies targeting PSMs to combat MRSA.
  • Informed antibiotic prescribing and infection control measures can be enhanced based on these insights.